Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Recent interviews and public appearances by Donald Trump have sparked comparisons to Ronald Reagan’s cognitive decline before his Alzheimer’s diagnosis, driven largely by linguistic analysis of his speech patterns. In January 2026, Trump referred to Greenland as “Iceland” multiple times during a Davos speech, an error that added fuel to ongoing concerns about potential cognitive changes.
While some experts point to measurable increases in filler words and sentence fragmentation similar to patterns observed in Reagan’s speeches before his diagnosis, other researchers emphasize critical limitations: Trump tested perfectly on a cognitive screening test in April 2025, and speech changes alone cannot definitively indicate dementia without additional clinical evidence. The comparisons have generated significant attention in mainstream media and among experts in neurolinguistics, psychology, and memory disorders. However, the question remains contested—are these linguistic changes evidence of pathological decline, or are they consistent with normal aging at age 78? This article examines the speech pattern evidence, the Reagan comparison, expert opinions, official test results, and the important caveats that researchers themselves stress when discussing these claims.
Table of Contents
- What Do Trump’s Recent Speeches Actually Show?
- What Do Neuroscientists and Psychologists Actually Claim?
- How Do Trump’s Speech Patterns Compare to Reagan’s?
- What About Trump’s Official Cognitive Assessment?
- Why Experts Caution Against Premature Conclusions
- What Would Constitute Actual Evidence of Cognitive Decline?
- Where Does This Leave Us Going Forward?
- Conclusion
What Do Trump’s Recent Speeches Actually Show?
Experts in neurolinguistics have identified measurable changes in Trump’s speech patterns over recent years compared to decades earlier. According to researchers who have analyzed his public statements, these changes include more frequent use of short sentences, confused word order, repetition of phrases and ideas, and extended digressions where he leaves a topic and never returns. The Greenland/Iceland confusion is not an isolated incident—it represents part of a broader pattern that linguists have documented through systematic analysis of his speeches and interviews. A key finding involves filler words.
A regression analysis comparing Trump’s speech over time found a significant increase in his use of fillers like “very,” “really,” and other padding words. Notably, this increase was “not significantly different from the rise previously found in President Ronald reagan‘s speech” in the decades before Reagan’s Alzheimer’s diagnosis became public. This parallel is what has prompted most of the Reagan comparisons, though experts caution that this similarity alone does not establish cognitive pathology. However, a critical limitation exists here: linguistic changes can result from many factors including age, stress, public speaking context, and communication style choices—not necessarily brain disease. Researchers emphasize that these variables “should not be used to infer a change in cognitive state” without additional clinical evidence, since linguistic analysis has not been validated as a diagnostic measure of cognitive decline in high-functioning individuals.
What Do Neuroscientists and Psychologists Actually Claim?
Several experts have made public statements suggesting Trump may be experiencing cognitive decline. A neuroscientist made the striking claim that Trump shows signs of frontotemporal dementia (a type of dementia that affects behavior and language), describing it as “something more dangerous” than Alzheimer’s because “what’s being disinhibited is his underlying malignant narcissism.” Dr. John Gartner, a clinical psychologist, has claimed Trump exhibits “clear signs of dementia” with “really severe language problems—he can’t complete sentences. He wanders off topic. He gets very confused.” Multiple experts in memory, psychology, and linguistics have noted deterioration in Trump’s speech and cognitive performance compared to decades ago.
These observations are made by legitimate researchers who study language and neurodegenerative disease. Their concerns are not baseless—the linguistic patterns they identify are real, measurable, and do resemble some patterns seen in neurodegenerative conditions. The limitation here is critical: these are expert opinions based on public observation, not clinical diagnoses. None of these experts have conducted formal neuropsychological testing of Trump. They are interpreting publicly available speech patterns without access to medical records, imaging studies, or comprehensive cognitive testing. A formal diagnosis of dementia or any neurodegenerative condition requires clinical evaluation by physicians, not linguistic analysis alone.
How Do Trump’s Speech Patterns Compare to Reagan’s?
The Reagan comparison rests on solid historical precedent. A 2015 peer-reviewed study found early linguistic signs of Ronald Reagan’s Alzheimer’s in his news conferences from the early 1980s—before his family announced his diagnosis in 1994. That study identified lexical and syntactic changes associated with Alzheimer’s onset in Reagan’s actual speech. This historical example gives the Trump comparisons some scientific grounding. The linguistic parallel is specific: the increase in Trump’s filler words over the decades matches the rate of increase previously documented in Reagan’s filler word usage in the years before his Alzheimer’s became clinically apparent.
This is a measurable similarity, not speculation. However, it’s also worth noting that Reagan lived to 93 and had a long public career spanning decades—his speech changes were detectable over an extended period using formal linguistic analysis. The important caveat is that one speech pattern—filler word increase—is not diagnostic of anything by itself. Many conditions, normal aging, and conscious speech choices can increase filler word usage. Reagan’s case is informative as a historical parallel, but it doesn’t prove that Trump’s filler word increase indicates Alzheimer’s or any other condition. Different people age differently, and linguistic patterns alone have significant limitations for cognitive assessment.
What About Trump’s Official Cognitive Assessment?
In April 2025, Trump reportedly took the Montreal Cognitive Assessment (MoCA), a standardized cognitive screening test, and scored a perfect 30 out of 30. This test is used clinically to detect moderate to severe cognitive impairment and has been administered to other public figures to assess cognitive health. A perfect score suggests no significant cognitive impairment was detected by this particular measure. This result directly contradicts the more alarming expert claims. If Trump has dementia or significant cognitive decline, one would expect some performance decline on a formal cognitive assessment.
The perfect score supports the idea that he does not have obvious, clinically significant cognitive impairment—at least not as measured by the MoCA. This is the strongest objective evidence available to the public. However, psychologists emphasize several limitations of this test for assessing high-functioning older adults. The MoCA is brief and designed to catch moderate to severe impairment—it may not reliably detect subtle cognitive decline in people with high baseline intelligence and strong verbal abilities. Additionally, cognitive function can fluctuate day to day, and a single test on a single day may not capture the full picture of someone’s cognitive health. Some forms of cognitive decline, particularly those affecting executive function or subtle memory processes, might not show up on a screening test like the MoCA.
Why Experts Caution Against Premature Conclusions
Researchers studying cognition and aging have stressed important methodological caveats about using speech analysis to infer cognitive status. One key principle: “linguistic changes should not be used to infer a change in cognitive state” because linguistic variables are not validated diagnostic measures. This is not just academic nitpicking—it reflects a real scientific limitation. A person’s choice of words, sentence length, and speaking style are influenced by context, stress, personality, deliberate communication choices, and aging—not just brain pathology. A significant portion of what appears to be cognitive decline in older adults may actually reflect normal aging.
One psychology professor noted that cognitive changes in older adults “should not be automatically pathologized,” and that “virtually nobody is as sharp at age 70 as they were at age 40.” This is a normal, expected change. Distinguishing between normal aging and disease-related cognitive impairment requires careful clinical assessment, not public speech analysis. The caveat that matters most: without comprehensive neuropsychological testing, brain imaging, and medical evaluation, no one—expert or otherwise—can diagnose or rule out dementia based on public interviews. The linguistic observations are real. The expert concerns are legitimate. But the leap from “speech patterns have changed” to “this person has dementia” is not scientifically justified based on public information alone.
What Would Constitute Actual Evidence of Cognitive Decline?
If serious cognitive decline were present, we would expect to see more than just linguistic changes. A comprehensive assessment would include formal neuropsychological testing beyond a screening tool, brain imaging studies (MRI, PET scan) to look for structural changes or abnormalities, blood tests for biomarkers associated with Alzheimer’s and other dementias, and assessment by neurologists and geriatricians. We would also expect to see functional decline—difficulty with tasks of daily life, work performance problems, or clear memory issues that others close to the person observe and report.
For public figures, evidence of cognitive decline is tricky to assess because their professional environment is carefully controlled. Staff assist with scheduling, preparation, and decision-making. High-functioning individuals can compensate for mild cognitive changes for years. The perfect score on the April 2025 cognitive screening test remains the most objective evidence available and suggests that if decline is occurring, it is not yet at a clinically significant level.
Where Does This Leave Us Going Forward?
The current state of public knowledge is genuinely uncertain. Measurable linguistic changes have occurred. Expert observers have identified patterns consistent with some forms of cognitive aging or decline.
At the same time, a cognitive screening test came back normal, and no formal clinical diagnosis exists. This is an example of a situation where reasonable people can disagree about what the evidence shows. Moving forward, further clarity would require either Trump himself consenting to comprehensive neuropsychological and neuroimaging evaluation (and publicly releasing those results), or evidence of functional decline that becomes impossible to hide or explain away through other means. Until then, the comparisons to Reagan remain speculative—informed by real linguistic changes and historical precedent, but not confirmed by clinical evidence.
Conclusion
Trump’s recent interviews and public statements have sparked genuine scientific interest and expert concern about potential cognitive changes, driven by measurable linguistic patterns that do resemble some aspects of Reagan’s speech before his Alzheimer’s diagnosis. The evidence includes documented increases in filler words, more fragmented sentence structure, and apparent digressions—real observations made by researchers who study language and neurodegenerative disease. However, the evidence for actual dementia remains inconclusive, with a perfect score on a cognitive screening test in April 2025 contradicting the more alarming claims, and researchers themselves cautioning that linguistic analysis cannot definitively diagnose cognitive conditions in high-functioning individuals. The broader lesson from this ongoing conversation is that aging, cognitive decline, and disease are complex phenomena that resist simple diagnosis from public observation.
Linguistic changes warrant attention and further evaluation, but they require clinical context to be meaningful. At 78, Trump—like any older adult—may experience some cognitive aging. Whether this represents normal aging or pathological decline cannot be determined without comprehensive clinical assessment. For now, the Reagan comparisons remain a provocative but unproven hypothesis rather than a settled conclusion.
